BioSpace News Archive

Biotech Bay

Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT.

January 3, 2024
·
1 min read
Genetown

Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

Keros Therapeutics, Inc. announced the pricing of an underwritten public offering of 3,500,000 shares of common stock, at a public offering price of $40.00 per share.

January 3, 2024
·
5 min read
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Stevanato Group S.p.A. announced that it will participate in the 42nd Annual J.P. Morgan Healthcare Conference taking place from January 8, 2024 to January 11, 2024 in San Francisco, California.

January 3, 2024
·
1 min read
Business

Simulations Plus Reports First Quarter Fiscal 2024 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first quarter fiscal 2024, ended November 30, 2023.

January 3, 2024
·
13 min read
Genetown

Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Disc Medicine, Inc. (NASDAQ:IRON) announced today that John Quisel, J.D., PhD., President and Chief Executive Officer, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10th at 2:15 pm PT / 5:15 pm ET.

January 3, 2024
·
1 min read
Biotech Bay

Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA

Nektar (Nasdaq: NKTR) management is scheduled to present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024 at 5:15 p.m. Pacific Time.

January 3, 2024
·
1 min read
Pharm Country

SELLAS Life Sciences Announces Proposed Public Offering - Jan 04, 2024

SELLAS Life Sciences Group, Inc. announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of common stock in a public offering.

January 3, 2024
·
4 min read
Business

MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR’s TCR-T Cell Pipeline

MaxCyte, Inc. today announced the signing of a strategic platform license (SPL).

January 3, 2024
·
4 min read
Genetown

Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8

Ardelyx, Inc. today announced it will host a live event and webcast on Monday, January 8, 2024, at 7:00 p.m. ET / 4:00 p.m. PT.

January 3, 2024
·
3 min read
Biotech Beach

OGM Added to International System for Human Cytogenomic Nomenclature

Bionano Genomics, Inc., announced a publication outlining the addition of optical genome mapping to the International System for Human Cytogenomic Nomenclature.

January 3, 2024
·
5 min read